Omer Bilgehan POYRAZOGLU, Turkmen Bahadir ARİKAN, Yunus DONDER, Ahmet Cumhur DULGER

Celiac disease prevalence in patients with hydatid cyst

Aim: Hydatid cyst (HC), which is localized in the liver and lungs in most cases, has been associated with a variety of hematologic and biochemical manifestations. Celiac disease (CD) is a small-intestinal malabsorption syndrome caused by hypersensitivity to gluten in subjects who carry the HLA haplotypes HLA DQ2 and DQ8. This study has attempted to show the connection between CD and HC.Material and Methods: We prospectively analyzed data from 211 HC patients, 62 of whom had extrahepatic involvement of HC; in addition, we also classified the patients’ hydatid cysts by their radiologic features. All patients tested positive for HC by ELISA. Sera from the study population were also analyzed for IgA and IgG with ELISA using human recombinant tTG (AESKU. Diagnostics,Germany); the data were then analyzed statistically.Results: Twelve cases of seropositivity of TTG IgA were found among patients with HC. In the control group, the rate of TTG IgG seropositivity was only 2 out of 211 patients (~2%), which was lower than those with HC. In patients with HC, the mean WBC level was higher in patients with TTG IgA seropositivity compared with those without TTG IgA seropositivity. Younger ages were independently associated with TTG IgA seropositivity in the HC group.Conclusion: This study furthers the understanding of CD risk in HC. If confirmed by future studies, the study’s data will assist in developing optimal strategies for the detection of CD in patients with HC. Understanding the infectious factors involved in CD is important for identifying new approaches to the early detection of CD.

PDF

___

Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357(17):1731-43.
Green PH, Krishnareddy S, Lebwohl B. Clinical manifestations of celiac disease. Dig Dis 2015;33(2):137-40.
Gatselis NK, Zachou K, Norman GL, Tzellas G, Speletas M, Gabeta S, et al. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases. Clin Chim Acta. 2012; 413(19-20):1683-8.
du Pré MF, Sollid LM. T-cell and B-cell immunity in celiac disease. Best Pract Res Clin Gastroenterol 2015;29(3):413-23.
Pang N, Zhang F, Ma X, Zhang Z, Zhao H, Xin Y. Th9/IL-9 profile in human echinococcosis: Their involvement in immune response during infection by Echinococcus granulosus. Mediators Inflamm. 2014;2014:781649.
Catassi C, Fabiani E, Corrao G, Barbato M, De Renzo A, Carella AM. Risk of non-Hodgkin lymphoma in celiac disease. JAMA 2002;287(11):1413-9.
Kondrashova A, Mustalahti K, Kaukinen K, Viskari H, Volodicheva V, Haapala AM, et al. Epivir Study Group. Lower economic status and inferior hygienic environment may protect against celiac disease. Ann Med 2008;40(3):223- 31.
Ludvigsson JF, Card TR, Kaukinen K, Bai J, Zingone F, Sanders DS, et al. Screening for celiac disease in the general population and in high-risk groups. United European Gastroenterol J 2015;3(2):106-20.
Godfrey JD, Brantner TL, Brinjikji W, Christensen KN, Brogan DL, Van Dyke CT, et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 2010;139(3):763-9.
Jafri MR, Nordstrom CW, Murray JA, Van Dyke CT, Dierkhising RA, Zinsmeister AR, et al. Long-term fracture risk in patients with celiac disease: Apopulation-based study in Olmsted County, Minnesota. Dig Dis Sci 2008;53(4):964-71.
Murray JA, Van Dyke C, Plevak MF, Dierkhising RA, Zinsmeister AR, Melton LJ III. Trends in the identification and clinical features of celiac disease in a North American community, 1950-2001. Clin Gastroenterol Hepatol 2003;1(1): 9-27.
Choung RS, Ditah IC, Nadeau AM, Rubio-Tapia A, Marietta EV, Brantner TL, et al. Trends and racial/ethnic disparities in gluten-sensitive problems in the United States: Findings from the National Health and Nutrition Examination Surveys from 1988 to 2012. Am J Gastroenterol 2015;110(3):455-61.
Barıs I, Sahin A, Bilir N, Kalyoncu AF, Emri AS, Akhan O, Barış B, Copur AS, Selcuk ZT. Hidatik kist hastalığı ve Türkiyedeki Konumu. Türkiye Akciğer Hastalıkları Vakfı Yayını No. 1, Ankara, 1989, p: 105.
Brunetti E, Junghanss T. Update on cystic hydatid disease. Curr Opin Infect Dis 2009;22(5):497-502.
Eckert J, Deplazes P. Biological, epidemiological, and clinical aspects of echinococcosis, a zoonosis of increasing concern. Clin Microbiol Rev 2004;17(1):107-35.
Craig PS, McManus DP, Lightowlers MW, Chabalgoity JA, Garcia HH, Gavidia CM, et al. Prevention and control of cystic echinococcosis. Lancet Infect Dis 2007;7(6):385-94.
Kebede W, Hagos A, Girma Z, Lobago F. Echinococcosis/ hydatidosis: Its prevalence, economic and public health significance in the Tigray region, North Ethiopia. Trop Anim Health Prod 2009;41(6):865-71.
Eckert J, Gemmell MA, Meslin F, Pawlowski ZS. WHO/OIE Manual on Echinococcosis in Humans and Animals: A Public Health Problem of Global Concern. Paris, France, World Organization for Animal Health (Office International des Epizooties) and Paris, France World Health Organization 2001;1-250.
Vieira SM, Pagovich OE, Kriegel MA. Diet, microbiota and autoimmune diseases. Lupus 2014;23(6):518-26.
Kratzer W, Kibele M, Akinli A, Porzner M, Boehm BO, Koenig W, et al. Prevalence of celiac disease in Germany: Aprospective follow-up study.World J Gastroenterol 2013;19(17): 612-20.
Moro PL, Schantz PM. Echinococcosis: historical landmarks and progress in research and control. Ann Trop Med Parasitol 2006;100(8):703-14.
Moro P, Schantz PM. Echinococcosis: a review. Int J Infect Dis 2009;13(2):125-33.